BioSpace News Archive

Rheumatology Therapeutics Market is Likely to Grow Around Worth of US$ 52.96 Bn by the End of 2025

The global rheumatology therapeutics market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research.

November 11, 2021
·
4 min read
Business

MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results

“Monjuvi sales continued to build momentum in the third quarter where we saw a broadening of the prescriber base and increased utilization in second-line patients,” said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys.

November 11, 2021
·
13 min read
Genome Engineering Market - Growing Number of Genomics Projects Drive the Industry Growth

The genome engineering market has been anticipated to experience noteworthy growth opportunities in the forthcoming years.

November 11, 2021
·
3 min read
Fluoroscopy Equipment Market to Register 6% CAGR as Demand for Multipurpose Imaging Tools Grows for Real-time Diagnosis

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global fluoroscopy equipment market size is estimated to exceed US$ 1.9 Bn in 2021.

November 11, 2021
·
8 min read
Ataxia Market Latest Report with Detailed Analysis and Forecast to 2030

The ataxia market has been anticipated to experience noteworthy growth prospects in the forthcoming years.

November 11, 2021
·
4 min read
Teleradiology Services Market is Expected to Elevate to a Value of US$ 19.7 Bn by the End of 2031

According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. It is projected to expand at a CAGR of ~11% from 2021 to 2031.

November 11, 2021
·
5 min read
Relief Provides Corporate Update and Outlines Plans to Advance its Diversified Portfolio of Pipeline Candidates, Including RLF-100(TM) (Aviptadil)

RELIEF THERAPEUTICS Holding SA provided a corporate update detailing, among other matters, its ongoing clinical development and regulatory activities, as well as its plans to accelerate the maturation of its pipeline.

November 11, 2021
·
9 min read
Business

Ultimovacs ASA: Third quarter 2021 result presentation

Oslo, 11November 2021: Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announces its third quarter 2021 results.

November 11, 2021
·
3 min read
Business

Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Dr. Heiner Dreismann to its Strategy Advisory Board.

November 11, 2021
·
5 min read
Business

Araris Biotech AG Expands Scientific Advisory Board with Appointment of Dr. Jeff Sharman and Dr. Clive Stanway

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate -linker technology, announced that the company is expanding its scientific advisory board with the appointment of Jeff Sharman, M.D. and Clive Stanway, Ph.D.

November 11, 2021
·
3 min read